RGS16 promotes glioma progression and serves as a prognostic factor.
CONCLUSIONS: RGS16 plays an important role in glioma progression and serves as an independent prognostic factor, especially in GBM patients.
PMID: 32319728 [PubMed - as supplied by publisher]
Source: CNS Neuroscience and Therapeutics - Category: Neuroscience Authors: Huang R, Li G, Zhao Z, Zeng F, Zhang K, Liu Y, Wang K, Hu H Tags: CNS Neurosci Ther Source Type: research
More News: Brain | Brain Tumor | Cancer | Cancer & Oncology | China Health | Databases & Libraries | Epithelial Cancer | Genetics | Glioma | Neurology | Neuroscience | Statistics | Students | Study | Universities & Medical Training